Sage Journals: Discover world-class research

Retricted access

Research article

First published 2014-9

An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy

Robert L Carruthers, Dalia L Rotstein, Brian C Healy [...]

Multiple Sclerosis Journal

Retricted access

Review article

First published 2018-4

Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters

Nicholas Schwab, Tilman Schneider-Hohendorf, Tammy Hoyt [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2025-6

Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?

Sandra Vukusic, Florian Hubben, Antoine Gavoille [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2015-10

Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy

Anke Vennegoor, Johannis A van Rossum, Chris H Polman [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2014-5

Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy

Robert L Carruthers, Tanuja Chitnis, Brian C Healy

Multiple Sclerosis Journal

Retricted access

Letter

First published 2025-3

Challenges and implications of anti-JCV antibody serology variability among different assays in natalizumab treatment: A call for standardization and transparency in clinical practice

Hernan Inojosa, Annika Kather, Katja Akgün [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2014-6

JC-virus seroconversion in multiple sclerosis patients receiving natalizumab

Olivier Outteryck, Hélène Zéphir, Julia Salleron [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2006-04

Human demyelinating disease and the polyomavirus JCV

K Khalili, M K White

Multiple Sclerosis Journal

Retricted access

Research article

First published 2012-8

Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision

Carmen Tur, Mar Tintoré, Angela Vidal-Jordana [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2016-03

Serological Survey for Antibodies to Mosquito-Borne Bunyaviruses Among US National Park Service and US Forest Service Employees

Olga Kosoy, Ingrid Rabe, Aimee Geissler [...]

Vector-Borne and Zoonotic Diseases

Search results